Søs Skovsø,Evgeniy Panzhinskiy,Jelena Kolic,Haoning Howard Cen,Derek A. Dionne,Xiao-Qing Dai,Rohit B. Sharma,Lynda Elghazi,Cara E. Ellis,Katharine Faulkner,Stephanie A. M. Marcil,Peter Overby,Nilou Noursadeghi,Daria Hutchinson,Xiaoke Hu,Hong Li,Honey Modi,Jennifer S. Wildi,J. Diego Botezelli,Hye Lim Noh,Sujin Suk,Brian Gablaski,Austin Bautista,Ryekjang Kim,Corentin Cras-Méneur,Stephane Flibotte,Sunita Sinha,Dan S. Luciani,Corey Nislow,Elizabeth J. Rideout,Eric N. Cytrynbaum,Jason K. Kim,Ernesto Bernal-Mizrachi,Laura C. Alonso,Patrick E. MacDonald,James D. Johnson

Abstract:Abstract Insulin receptor (Insr) protein is present at higher levels in pancreatic β-cells than in most other tissues, but the consequences of β-cell insulin resistance remain enigmatic. Here, we use an Ins1 cre knock-in allele to delete Insr specifically in β-cells of both female and male mice. We compare experimental mice to Ins1 cre -containing littermate controls at multiple ages and on multiple diets. RNA-seq of purified recombined β-cells reveals transcriptomic consequences of Insr loss, which differ between female and male mice. Action potential and calcium oscillation frequencies are increased in Insr knockout β-cells from female, but not male mice, whereas only male β Insr KO islets have reduced ATP-coupled oxygen consumption rate and reduced expression of genes involved in ATP synthesis. Female β Insr KO and β Insr HET mice exhibit elevated insulin release in ex vivo perifusion experiments, during hyperglycemic clamps, and following i.p . glucose challenge. Deletion of Insr does not alter β-cell area up to 9 months of age, nor does it impair hyperglycemia-induced proliferation. Based on our data, we adapt a mathematical model to include β-cell insulin resistance, which predicts that β-cell Insr knockout improves glucose tolerance depending on the degree of whole-body insulin resistance. Indeed, glucose tolerance is significantly improved in female β Insr KO and β Insr HET mice compared to controls at 9, 21 and 39 weeks, and also in insulin-sensitive 4-week old males. We observe no improved glucose tolerance in older male mice or in high fat diet-fed mice, corroborating the prediction that global insulin resistance obscures the effects of β-cell specific insulin resistance. The propensity for hyperinsulinemia is associated with mildly reduced fasting glucose and increased body weight. We further validate our main in vivo findings using an Ins1 -CreERT transgenic line and find that male mice have improved glucose tolerance 4 weeks after tamoxifen-mediated Insr deletion. Collectively, our data show that β-cell insulin resistance in the form of reduced β-cell Insr contributes to hyperinsulinemia in the context of glucose stimulation, thereby improving glucose homeostasis in otherwise insulin sensitive sex, dietary and age contexts.

Beta-cell Cre expression and reduced Ins1 gene dosage protect mice from type 1 diabetes

Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells

Gene Therapy with Neurogenin3, Betacellulin and SOCS1 Reverses Diabetes in NOD Mice

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages

Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance

Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice

β-Cell Deletion of Hypoxia-Inducible Factor 1α (HIF-1α) Increases Pancreatic β-Cell Susceptibility to Streptozotocin

Generation and Characterization of Transgenic Mice Expressing Mouse Ins1 Promoter for Pancreatic Β-Cell-specific Gene Overexpression and Knockout.

Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes

Differentiation and Transplantation of Functional Pancreatic Beta Cells Generated from Induced Pluripotent Stem Cells Derived from a Type 1 Diabetes Mouse Model

Transgenic Insulin (B:9-23) T-Cell Receptor Mice Develop Autoimmune Diabetes Dependent Upon RAG Genotype, H-2g7 Homozygosity, and Insulin 2 Gene Knockout

Beta cells deficient for Renalase counteract autoimmunity by shaping natural killer cell activity

Generation of CRISPR/Cas9-mediated bicistronic knock-in ins1-cre driver mice

Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice

Type 1 diabetes induction in humanized mice.

P21cip-overexpression in the Mouse Beta Cells Leads to the Improved Recovery from Streptozotocin-Induced Diabetes.

Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia

Inducing Specific Immune Tolerance to Prevent Type 1 Diabetes in NOD Mice.

B Lymphocytes Expressing High Levels of PD-L1 Are Key Regulators of Diabetes Development in Non-Obese Diabetic Mice.

Pancreatic-specific Inactivation of IGF-I Gene Causes Enlarged Pancreatic Islets and Significant Resistance to Diabetes.